Dauth Alice, Bręborowicz Andrzej, Ruan Yue, Tang Qi, Zadeh Jenia K, Böhm Elsa W, Pfeiffer Norbert, Khedkar Pratik H, Patzak Andreas, Vujacic-Mirski Ksenija, Daiber Andreas, Gericke Adrian
Department of Neurosurgery, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
Department of Ophthalmology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
Antioxidants (Basel). 2023 Feb 6;12(2):388. doi: 10.3390/antiox12020388.
Diabetes mellitus may cause severe damage to retinal blood vessels. The central aim of this study was to test the hypothesis that sulodexide, a mixture of glycosaminoglycans, has a protective effect against hyperglycemia-induced endothelial dysfunction in the retina. Functional studies were performed in isolated porcine retinal arterioles. Vessels were cannulated and incubated with highly concentrated glucose solution (HG, 25 mM D-glucose) +/- sulodexide (50/5/0.5 μg/mL) or normally concentrated glucose solution (NG, 5.5 mM D-glucose) +/- sulodexide for two hours. Endothelium-dependent and endothelium-independent vasodilatation were measured by videomicroscopy. Reactive oxygen species (ROS) were quantified by dihydroethidium (DHE) fluorescence. Using high-pressure liquid chromatography (HPLC), the intrinsic antioxidant properties of sulodexide were investigated. Quantitative PCR was used to determine mRNA expression of regulatory, inflammatory, and redox genes in retinal arterioles, some of which were subsequently quantified at the protein level by immunofluorescence microscopy. Incubation of retinal arterioles with HG caused significant impairment of endothelium-dependent vasodilation, whereas endothelium-independent responses were not affected. In the HG group, ROS formation was markedly increased in the vascular wall. Strikingly, sulodexide had a protective effect against hyperglycemia-induced ROS formation in the vascular wall and had a concentration-dependent protective effect against endothelial dysfunction. Although sulodexide itself had only negligible antioxidant properties, it prevented hyperglycemia-induced overexpression of the pro-oxidant redox enzymes, NOX4 and NOX5. The data of the present study provide evidence that sulodexide has a protective effect against hyperglycemia-induced oxidative stress and endothelial dysfunction in porcine retinal arterioles, possibly by modulation of redox enzyme expression.
糖尿病可能会对视网膜血管造成严重损害。本研究的主要目的是验证以下假设:糖胺聚糖混合物舒洛地昔对高血糖诱导的视网膜内皮功能障碍具有保护作用。在分离的猪视网膜小动脉上进行功能研究。将血管插管并与高浓度葡萄糖溶液(HG,25 mM D-葡萄糖)+/-舒洛地昔(50/5/0.5 μg/mL)或正常浓度葡萄糖溶液(NG,5.5 mM D-葡萄糖)+/-舒洛地昔一起孵育两小时。通过视频显微镜测量内皮依赖性和非内皮依赖性血管舒张。用二氢乙锭(DHE)荧光对活性氧(ROS)进行定量。使用高压液相色谱(HPLC)研究舒洛地昔的内在抗氧化特性。采用定量PCR测定视网膜小动脉中调节、炎症和氧化还原基因的mRNA表达,其中一些基因随后通过免疫荧光显微镜在蛋白质水平进行定量。用HG孵育视网膜小动脉会导致内皮依赖性血管舒张显著受损,而非内皮依赖性反应不受影响。在HG组中,血管壁中的ROS形成明显增加。引人注目的是,舒洛地昔对高血糖诱导的血管壁ROS形成具有保护作用,并且对内皮功能障碍具有浓度依赖性保护作用。尽管舒洛地昔本身仅具有可忽略不计的抗氧化特性,但它可防止高血糖诱导的促氧化还原酶NOX4和NOX5的过度表达。本研究数据表明,舒洛地昔可能通过调节氧化还原酶表达,对高血糖诱导的猪视网膜小动脉氧化应激和内皮功能障碍具有保护作用。